UK MHRA Falls Behind On Fee Consultation While Regulatory Costs Mount
This article was originally published in Clinica
Executive Summary
The widely anticipated UK MHRA consultation on medical device fees is being delayed as official processes of scrutiny are still being finalized. However, the agency’s director of devices John Wilkinson was upbeat at last week’s ABHI annual regulatory conference, saying: “We hope the consultation will be out next month, and when released it will be a proper exercise of six weeks or so.”